240 related articles for article (PubMed ID: 20350125)
1. Pharmacogenomics of membrane transporters: past, present and future.
Yee SW; Chen L; Giacomini KM
Pharmacogenomics; 2010 Apr; 11(4):475-9. PubMed ID: 20350125
[TBL] [Abstract][Full Text] [Related]
2. The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.
Kroetz DL; Yee SW; Giacomini KM
Clin Pharmacol Ther; 2010 Jan; 87(1):109-16. PubMed ID: 19940846
[TBL] [Abstract][Full Text] [Related]
3. [The pharmacogenomics of drug transporters: functional analysis approaches].
Ishikawa T; Endou H; Inui K; Tsuji A; Wada M; Sumino Y
Tanpakushitsu Kakusan Koso; 2004 Sep; 49(12):2024-34. PubMed ID: 15449720
[No Abstract] [Full Text] [Related]
4. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
5. Human membrane transporter database: a Web-accessible relational database for drug transport studies and pharmacogenomics.
Yan Q; Sadée W
AAPS PharmSci; 2000; 2(3):E20. PubMed ID: 11741236
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform.
Sissung TM; English BC; Venzon D; Figg WD; Deeken JF
Pharmacogenomics; 2010 Jan; 11(1):89-103. PubMed ID: 20017675
[TBL] [Abstract][Full Text] [Related]
7. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).
Gradhand U; Kim RB
Drug Metab Rev; 2008; 40(2):317-54. PubMed ID: 18464048
[TBL] [Abstract][Full Text] [Related]
9. Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transporters.
Kim V; Wal TV; Nishi MY; Montenegro LR; Carrilho FJ; Hoshida Y; Ono SK
Pharmacogenomics; 2020 Jun; 21(9):575-586. PubMed ID: 32486903
[No Abstract] [Full Text] [Related]
10. Pharmacogenomics and systems biology of membrane transporters.
Yan Q
Mol Biotechnol; 2005 Jan; 29(1):75-88. PubMed ID: 15668521
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics: past, present and future.
Pirmohamed M
Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816
[TBL] [Abstract][Full Text] [Related]
12. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of the OATP and OAT families.
Marzolini C; Tirona RG; Kim RB
Pharmacogenomics; 2004 Apr; 5(3):273-82. PubMed ID: 15102542
[TBL] [Abstract][Full Text] [Related]
14. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
Lesko LJ; Zineh I
Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
[TBL] [Abstract][Full Text] [Related]
15. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
Alfirevic A; Pirmohamed M
Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
[TBL] [Abstract][Full Text] [Related]
17. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
Rodieux F; Gotta V; Pfister M; van den Anker JN
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
[TBL] [Abstract][Full Text] [Related]
18. PharmGKB: understanding the effects of individual genetic variants.
Sangkuhl K; Berlin DS; Altman RB; Klein TE
Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
[TBL] [Abstract][Full Text] [Related]
19. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
